Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration

Neurochemistry International

Volumn 50, Issue 3, 2007, Pages 524-530

  Yao, Jianhua S ^a   Shen, Fanxia ^a   Young, William L ^a   Yang, Guo Yuan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Doxycycline; Matrix metalloproteinase; Migration; Minocycline; Smooth muscle cell; Vascular endothelial growth factor

Indexed keywords

DOXYCYCLINE; GELATINASE B; MINOCYCLINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BASE SEQUENCE; CELL MOVEMENT; CELLS, CULTURED; DNA PRIMERS; DOXYCYCLINE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MINOCYCLINE; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846588942     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.10.008     Document Type: Article

References (53)

1. Bendeck M.P., Conte M., Zhang M., Nili N., Strauss B.H., and Farwell S.M. Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. Am. J. Pathol. 160 (2002) 1089-1095
2. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., and Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2 (2000) 737-744
3. Bettany J.T., and Wolowacz R.G. Tetracycline derivatives induce apoptosis selectively in cultured monocytes and macrophages but not in mesenchymal cells. Adv. Dent. Res. 12 (1998) 136-143
4. De Clerck Y.A., Yean T.D., Ratzkin B.J., Lu H.S., and Langley K.E. Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J. Biol. Chem. 264 (1989) 17445-17453
5. Fabunmi R.P., Baker A.H., Murray E.J., Booth R.F., and Newby A.C. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem. J. 315 Pt 1 (1996) 335-342
6. Fanburg B.L., and Lee S.L. A new role for an old molecule: serotonin as a mitogen. Am. J. Physiol. 272 (1997) L795-L806
7. Fife R.S., Rougraff B.T., Proctor C., and Sledge Jr. G.W. Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells. J. Lab. Clin. Med. 130 (1997) 530-534
8. Fife R.S., and Sledge Jr. G.W. Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells. J. Lab. Clin. Med. 125 (1995) 407-411
9. Fife R.S., Sledge Jr. G.W., Sissons S., and Zerler B. Effects of tetracyclines on angiogenesis in vitro. Cancer Lett. 153 (2000) 75-78
10. Forough R., Koyama N., Hasenstab D., Lea H., Clowes M., Nikkari S.T., and Clowes A.W. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ. Res. 79 (1996) 812-820
11. Galis Z.S., Muszynski M., Sukhova G.K., Simon-Morrissey E., Unemori E.N., Lark M.W., Amento E., and Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75 (1994) 181-189
12. Gerber H.P., McMurtrey A., Kowalski J., Yan M., Keyt B.A., Dixit V., and Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273 (1998) 30336-30343
13. Gilbertson-Beadling S., Powers E.A., Stamp-Cole M., Scott P.S., Wallace T.L., Copeland J., Petzold G., Mitchell M., Ledbetter S., and Poorman R. The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism. Cancer Chemother. Pharmacol. 36 (1995) 418-424
14. Golub L.M., Lee H.M., Ryan M.E., Giannobile W.V., Payne J., and Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv. Dent. Res. 12 (1998) 12-26
15. Golub L.M., Ramamurthy N.S., McNamara T.F., Greenwald R.A., and Rifkin B.R. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit. Rev. Oral Biol. Med. 2 (1991) 297-321
16. Goncharova E.A., Ammit A.J., Irani C., Carroll R.G., Eszterhas A.J., Panettieri R.A., and Krymskaya V.P. PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 283 (2002) L354-L363
17. Grosskreutz C.L., Anand-Apte B., Duplaa C., Quinn T.P., Terman B.I., Zetter B., and D'Amore P.A. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc. Res. 58 (1999) 128-136
18. Guo D., Jia Q., Song H.Y., Warren R.S., and Donner D.B. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270 (1995) 6729-6733
19. Hashimoto G., Inoki I., Fujii Y., Aoki T., Ikeda E., and Okada Y. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J. Biol. Chem. 277 (2002) 36288-36295
20. Hashimoto T., Wu Y., Lawton M.T., Yang G.-Y., Barbaro N.M., and Young W.L. Co-expression of angiogenic factors in brain arteriovenous malformations. Neurosurgery 56 (2005) 1058-1065 discussion
21. Hayashi T., Noshita N., Sugawara T., and Chan P.H. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J. Cereb. Blood Flow Metab. 23 (2003) 166-180
22. Imai Y., and Clemmons D.R. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I. Endocrinology 140 (1999) 4228-4235
23. Knall C., Worthen G.S., and Johnson G.L. Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc. Natl. Acad Sci. U.S.A. 94 (1997) 3052-3057
24. Lamoreaux W.J., Fitzgerald M.E., Reiner A., Hasty K.A., and Charles S.T. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc. Res. 55 (1998) 29-42
25. Lee C.Z., Xu B., Hashimoto T., McCulloch C.E., Yang G.Y., and Young W.L. Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke 35 (2004) 1715-1719
26. Lee C.Z., Yao J.S., Huang Y., Zhai W., Liu W., Guglielmo B.J., Lin E., Yang G.-Y., and Young W.L. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. J. Cereb. Blood Flow Metab. 26 (2006) 1157-1164
27. Lokeshwar B.L., Selzer M.G., Zhu B.Q., Block N.L., and Golub L.M. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. Int. J. Cancer. 98 (2002) 297-309
28. Meier C.R., Derby L.E., Jick S.S., Vasilakis C., and Jick H. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA 281 (1999) 427-431
29. Mohle R., Green D., Moore M.A., Nachman R.L., and Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad Sci. U.S.A. 94 (1997) 663-668
30. Nelson M.L. Chemical and biological dynamics of tetracyclines. Adv. Dent. Res. 12 (1998) 5-11
31. Nip L.H., Uitto V.J., and Golub L.M. Inhibition of epithelial cell matrix metalloproteinases by tetracyclines. J. Periodontal. Res. 28 (1993) 379-385
32. Okada Y., Gonoji Y., Naka K., Tomita K., Nakanishi I., Iwata K., Yamashita K., and Hayakawa T. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267 (1992) 21712-21719
33. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75 (1995) 487-517
34. Pauly R.R., Passaniti A., Bilato C., Monticone R., Cheng L., Papadopoulos N., Gluzband Y.A., Smith L., Weinstein C., Lakatta E.G., et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ. Res. 75 (1994) 41-54
35. Ramamurthy N.S., Vernillo A.T., Greenwald R.A., Lee H.M., Sorsa T., Golub L.M., and Rifkin B.R. Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J. Bone. Miner. Res. 8 (1993) 1247-1253
36. Roeb E., Graeve L., Hoffmann R., Decker K., Edwards D.R., and Heinrich P.C. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology 18 (1993) 1437-1442
37. Rosenberg G.A., and Navratil M.J. (S)-Emopamil reduces brain edema from collagenase-induced hemorrhage in rats. Stroke 25 (1994) 2067-2071
38. Ross R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57 (1995) 791-804
39. Ryan M.E., Ramamurthy S., and Golub L.M. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr. Opin. Periodontol. 3 (1996) 85-96
40. Seftor R.E., Seftor E.A., De Larco J.E., Kleiner D.E., Leferson J., Stetler-Stevenson W.G., McNamara T.F., Golub L.M., and Hendrix M.J. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin. Exp. Metastasis 16 (1998) 217-225
41. Senior R.M., Griffin G.L., Fliszar C.J., Shapiro S.D., Goldberg G.I., and Welgus H.G. Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266 (1991) 7870-7875
42. Shapiro S.D., Kobayashi D.K., and Welgus H.G. Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1. J. Biol. Chem. 267 (1992) 13890-13894
43. Smith Jr. G.N., Brandt K.D., and Hasty K.A. Activation of recombinant human neutrophil procollagenase in the presence of doxycycline results in fragmentation of the enzyme and loss of enzyme activity. Arthritis Rheum. 39 (1996) 235-244
44. Southgate K.M., Davies M., Booth R.F., and Newby A.C. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem. J. 288 Pt 1 (1992) 93-99
45. Stenmark K.R., and Mecham R.P. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu. Rev. Physiol. 59 (1997) 89-144
46. Stricklin G.P., and Welgus H.G. Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J. Biol. Chem. 258 (1983) 12252-12258
47. Tamargo R.J., Bok R.A., and Brem H. Angiogenesis inhibition by minocycline. Cancer Res. 51 (1991) 672-675
48. Tronc F., Mallat Z., Lehoux S., Wassef M., Esposito B., and Tedgui A. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler. Thromb. Vasc. Biol. 20 (2000) E120-E126
49. Uitto V.J., Firth J.D., Nip L., and Golub L.M. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann. N.Y. Acad. Sci. 732 (1994) 140-151
50. Wang H., and Keiser J.A. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1 (in process citation). Circ. Res. 83 (1998) 832-840
51. Welgus H.G., and Stricklin G.P. Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J. Biol. Chem. 258 (1983) 12259-12264
52. Yang G.Y., Yao J.S., Huey M., Hashimoto T., and Young W.L. Participation of PI3K and ERK1/2 pathways are required for human brain vascular smooth muscle cell migration. Neurochem. Int. 44 (2004) 441-446
53. Yao J.S., Chen Y., Zhai W., Xu K., Young W.L., and Yang G.-Y. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases. Circ. Res. 95 (2004) 364-371